![Eric Poma](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 563 $ al 31/07/2026
Dr. Eric E.
Poma is a Chairman & Chief Executive Officer at Calidi Biotherapeutics (Nevada), Inc., a Chief Executive Officer & Director at Calidi Biotherapeutics, Inc., a Chief Executive Officer & Director at Molecular Templates, Inc. and a Chief Executive Officer & Director at Molecular Templates OpCo, Inc. He is on the Board of Directors at Calidi Biotherapeutics, Inc., Molecular Templates, Inc. and Molecular Templates OpCo, Inc. Dr. Poma was previously employed as a Vice President-Business Development by Innovive Pharmaceuticals, Inc. and an Assistant Vice President-Business Development by ImClone LLC.
He received his undergraduate degree from the University of North Carolina at Chapel Hill, an MBA from The Leonard N Stern School of Business and a doctorate degree from the University of North Carolina at Chapel Hill.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/08/2026 | 1.563 ( 0,06 % ) | 2 563 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Director Ejecutivo | 01/01/2000 |
| CALIDI BIOTHERAPEUTICS, INC. | Director Ejecutivo | 22/04/2025 |
Molecular Templates OpCo, Inc.
 Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Director Ejecutivo | - |
Calidi Biotherapeutics, Inc. (United States)
 Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Director Ejecutivo | 22/04/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Corporate Officer/Principal | - |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
Calidi Biotherapeutics, Inc. (United States)
Calidi Biotherapeutics, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage immuno-oncology company | Commercial Services |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Calidi Biotherapeutics, Inc.
 Calidi Biotherapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies which attacks solid tumors | Health Technology |
University of North Carolina at Chapel Hill
 University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
